Eli
CLAYMONT, Delaware · Venture Capital Fund
Eli is a women's health company on a mission to improve lifelong health through continuous hormone monitoring. Hormones impact physical and mental health every day and at every stage of life. Eli offers real-time insights from hormones in saliva that can be tracked continuously over time, unlike traditional testing methods or send-out tests that only provide a single snapshot. With just three s
Key facts
- Headquarters
- CLAYMONT, Delaware
- Employees
- Unknown
- Industries
- Venture Capital Fund
- Status
- Private
- Website
- eli.health
- Company page
Recent activity at Eli
- : Eli raises $12M in Series A funding led by BDC Capital’s Thrive Venture Fund to launch Hormometer, a real-time hormone monitor, with support from Muse Capital and TELUS Global Ventures.
- : ELI, Inc. launched CTX Active Learning, a learning system aimed at improving workplace civility and results.
- : Healthcare Tech Company Eli Lands C$5M Seed
Eli funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2025 | Series A | $12.0M |
| Apr 2023 | Seed | $5.0M |
Leadership
- Taylor Hughes, Executive Officer
- LLC Sydecar, Director
- Marina Pavlovic Rivas, Chief Executive Officer
- Thomas Cortina, Chief Technology Officer
Verified email and direct lines for Eli’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Eli files 10 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Eli in the news
- Eli Lilly study finds Zepbound lowers healthcare costs over time - Healthcare Finance News (Aug 26, 2026)
- Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions - Eli Lilly (Jul 16, 2026)
- Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports - Reuters (Jul 15, 2026)
- Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction - CNBC (Jul 16, 2026)
- Hospitals irate after Eli Lilly follows through on 340B ultimatum - Healthcare Dive (Jun 22, 2026)
- How Much Difference Will Eli Lilly’s Half-Price Insulin Make? - KFF Health News (Apr 23, 2026)
- Tampa General Hospital sues Eli Lilly over reporting demands for 340B discounts - WUSF (Jul 10, 2026)
- Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide - NewsNation (Jul 26, 2026)
Companies similar to Eli
About Eli: questions and answers
What does Eli do?
Eli is a women's health company on a mission to improve lifelong health through continuous hormone monitoring. Hormones impact physical and mental health every day and at every stage of life. Eli offers real-time insights from hormones in saliva that can be tracked continuously over time, unlike traditional testing methods or send-out tests that only provide a single snapshot. With just three s
Where is Eli headquartered?
Eli is headquartered in CLAYMONT, Delaware.
Has Eli raised funding?
Yes. Fundz has recorded 2 funding events for Eli. The most recent, Series A of $12.0M, was in Jun 2025.
Who leads Eli?
Marina Pavlovic Rivas is a Chief Executive Officer at Eli.
What is the latest news on Eli?
On Jun 12, 2025, Eli raises $12M in Series A funding led by BDC Capital’s Thrive Venture Fund to launch Hormometer, a real-time hormone monitor, with support from Muse Capital and TELUS Global Ventures.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy